To better understand why some cancer patients struggle to fight off infections, Georgia Tech researchers have created tiny ...

The miniature models have the potential to significantly speed up vaccine development, advance cancer treatment research, and enhance health outcomes for a wide range of diseases. To gain deeper ...

AAV production results in a mix of capsids ... and amplify biological materials such as antibodies, proteins, nucleic acids, ...

Our synthetic hydrogels create a breakthrough environment for human immune organoids, allowing us to model antibody production from scratch ... mark a shift toward in vitro models that more closely ...

SEKISUI Diagnostics' microbial CDMO business announces it has completed construction of its £15.7 million ($20.7 million) cGMP capacity expansion at its UK site for clinical-grade drug substance ...

Our platforms also enable efficient production of complex antigens and antibodies, essential for developing vaccines ...

Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with cancer and inflammatory diseases, today ...

Planegg/Martinsried, November 11, 2024.Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused ...

RNA vaccines saved lives during the COVID-19 pandemic, but older people had less of an immune response to the vaccines than ...

And these data continue to demonstrate broad cross-neutralizing antibody responses to each new strain ... And we believe ...